Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
ORAMED PHARMACEUTICALS INC. has filed 932 SEC EDGAR filings since 29 Nov 2002

SEC filing history

Showing 226-250 of 773 matching filings.

Per page
25
Current page
10
4

4 filing

Filing date
30 Dec 2021
Reporting date
28 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Dec 2021
Reporting date
16 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
08 Dec 2021
Reporting date
07 Dec 2021
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
07 Dec 2021
Reporting date
07 Dec 2021
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
07 Dec 2021
Reporting date
03 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
07 Dec 2021
Reporting date
09 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
07 Dec 2021
Reporting date
31 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-35813

ANNUAL REPORT

Filing date
24 Nov 2021
Reporting date
31 Aug 2021
Next action
Verify source filing
424B5 File 333-257926

PROSPECTUS SUPPLEMENT

Filing date
04 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
04 Nov 2021
Reporting date
03 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
29 Oct 2021
Reporting date
29 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
5

OWNERSHIP DOCUMENT

Filing date
15 Oct 2021
Reporting date
31 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Sep 2021
Reporting date
16 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79895

AMENDMENT NO. 5 TO SCHEDULE 13D

Filing date
02 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Sep 2021
Reporting date
01 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Sep 2021
Reporting date
31 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Sep 2021
Reporting date
31 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Sep 2021
Reporting date
31 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Sep 2021
Reporting date
31 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
01 Sep 2021
Reporting date
26 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-257926

PROSPECTUS SUPPLEMENT

Filing date
01 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
31 Aug 2021
Reporting date
30 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B7 File 333-252696

424B7

Filing date
13 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Aug 2021
Reporting date
09 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Aug 2021
Reporting date
09 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .